A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid Tumors

Clinical trial NCT01235416 · COMPLETED

Trial details

NCT number: NCT01235416
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Histologically or Cytologically Documented Solid Tumors

Start date: 2005-09-01
Primary completion: 2008-04-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.